Multidrug Resistant Shigella flexneri Infection Simulating Intestinal Intussusception

ABSTRACT

Shigella enteritis remains an important cause of mortality and morbidity in all age groups, in developing as well as developed countries. Owing to the emerging resistance to multiple antibiotics among Shigella spp., it has been recognized as a major global public health concern and warrants constant monitoring of its resistance pattern. We report a case of segmental ileitis caused by non-ESBL producing multidrug resistant Shigella flexneri in an infant clinically mimicking intussusception, which was effectively treated by ceftriaxone.

Keywords

Bacillary dysentery - multidrug resistant - Shigella flexneri

Publication History

Article published online:
19 April 2020

• REFERENCES

• 1 Djie-Maletz A, Reither K, Danour S, Anyidoho L, Saad E, Danikuu F, et al. High rate of resistance to locally used antibiotics among enteric bacteria from children in Northern Ghana. J Antimicrob Chemother 2008;61:1315-8.
• 2 Khan WA, Griffiths JK, Bennish ML. Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic. PLoS One 2013;8:e64097.
• 3 Bhattacharya D, Sugunan AP, Bhattacharjee H, Thamizhmani R, Sayi DS, Thanasekaran K, et al. Antimicrobial resistance in Shigella – rapid increase and widening of spectrum in Andaman Islands, India. Indian J Med Res 2012;135:365-70.
• 4 Nandy S, Mitra U, Rajendran K, Dutta P, Dutta S. Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001-2007): A hospital-based study. Trop Med Int Health 2010;15:1499-507.
• 5 Rahman M, Shoma S, Rashid H, El Arifeen S, Baqui AH, Siddique AK, et al. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: Resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr 2007;25:158-67.
• 6 Gu B, Ke X, Pan S, Cao Y, Zhuang L, Yu R, et al. Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999-2010. J Biomed Res 2013;27:103-15.
• 7 Murphy MS. Management of bloody diarrhoea in children in primary care. BMJ 2008;336:1010-5.
• 8 Pazhani GP, Ramamurthy T, Mitra U, Bhattacharya SK, Niyogi SK. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol Infect 2005;133:1089-95.
• 9 Zaidi MB, Estrada-García T, Campos FD, Chim R, Arjona F, Leon M, et al. Incidence, clinical presentation, and antimicrobial resistance trends in Salmonella and Shigella infections from children in Yucatan, Mexico. Front Microbiol 2013;4:288.
• 10 Özmert EN, Ince OT, Örün E, Yalçin S, Yurdakök K, Gür D. Clinical characteristics and antibiotic resistance of Shigella gastroenteritis in Ankara, Turkey between 2003 and 2009, and comparison with previous reports. Int J Infect Dis 2011;15:e849-53.
• 11 World Health Organization. Guidelines for the Control of Shigellosis, Including Epidemics due to Shigella Dysenteriae Type 1. Geneva: World Health Organization; 2005. Available from: http://www.whqlibdoc.who.int/publications/2005/9241592330.p. [Last cited on 2014 Jan 12].
• 12 Bhattacharya D, Bhattacharjee H, Ramanathan T, Sudharma SD, Singhania M, Sugunan AP, et al. Third-generation cephalosporin resistance in clinical isolate of Shigella sonnei in Andaman and Nicobar Islands, India. J Infect Dev Ctries 2011;5:674-6.